Multiple myeloma (MM) is a lymphoproliferative disorder which is characterized by an accumulation of clonotypic plasma, cells in the bone marrow leading to an overproduction of monoclonal immunoglobulin (mIg). The disease often implies a poor prognosis. lg-reactive T-cells in MM have been described previously and lg- and dendritic cell (DC)-based immunotherapies in order to elicit and-rumour activity have been attempted in MM. DCs are efficient antigen presenting cells and important in both innate and adaptive immunity. The present study aimed at investigating lymphocyte functions underlying immune mechanisms associated with MM. In the first part of the study we show that mature monocyte-derived DCS from MM patients are suscept...
Multiple Myeloma (MM) is a plasma cell malignancy characterized by immunosuppression and increase of...
Multiple myeloma (MM) is a plasma cell malignancy associated with high levels of monoclonal (M) prot...
Background: Plasmacytoid dendritic cells (pDCs) play prominent roles in mediating innate and adaptiv...
Multiple myeloma (MM) is a lymphoproliferative disorder which is characterized by an accumulation of...
Multiple myeloma (MM) is a tumor of terminally differentiated B cells that arises in the bone marrow...
Natural Killer cells (NK) are innate effector cells with a critical role in immunosurveillance again...
The BDCA antibodies allowed reliable measurement of dendritic cell (DC) subsets and B cell numbers i...
While vaccination with antigen-pulsed dendritic cells (DCs) represents a promising therapeutic strat...
Activation and expansion of T helper (Th) cells followed by regulation of activation are essential t...
The bone marrow microenvironment interacts with malignant cells and regulates cancer survival and im...
Multiple Myeloma (MM) is a plasma cell malignancy characterized by immunosuppression and increase of...
Multiple myeloma (MM) is a plasma cell malignancy that presents with bone marrow plasmacytosis, mono...
Despite major advances in pharmacotherapy for Multiple Myeloma (MM) it remains incurable. Efforts ar...
In multiple myeloma (MM), dendritic cells (DCs), and their precursors are prone to malignant cell-me...
Multiple myeloma (MM) is a heterogeneous plasma cell malignancy differing substantially in clinical ...
Multiple Myeloma (MM) is a plasma cell malignancy characterized by immunosuppression and increase of...
Multiple myeloma (MM) is a plasma cell malignancy associated with high levels of monoclonal (M) prot...
Background: Plasmacytoid dendritic cells (pDCs) play prominent roles in mediating innate and adaptiv...
Multiple myeloma (MM) is a lymphoproliferative disorder which is characterized by an accumulation of...
Multiple myeloma (MM) is a tumor of terminally differentiated B cells that arises in the bone marrow...
Natural Killer cells (NK) are innate effector cells with a critical role in immunosurveillance again...
The BDCA antibodies allowed reliable measurement of dendritic cell (DC) subsets and B cell numbers i...
While vaccination with antigen-pulsed dendritic cells (DCs) represents a promising therapeutic strat...
Activation and expansion of T helper (Th) cells followed by regulation of activation are essential t...
The bone marrow microenvironment interacts with malignant cells and regulates cancer survival and im...
Multiple Myeloma (MM) is a plasma cell malignancy characterized by immunosuppression and increase of...
Multiple myeloma (MM) is a plasma cell malignancy that presents with bone marrow plasmacytosis, mono...
Despite major advances in pharmacotherapy for Multiple Myeloma (MM) it remains incurable. Efforts ar...
In multiple myeloma (MM), dendritic cells (DCs), and their precursors are prone to malignant cell-me...
Multiple myeloma (MM) is a heterogeneous plasma cell malignancy differing substantially in clinical ...
Multiple Myeloma (MM) is a plasma cell malignancy characterized by immunosuppression and increase of...
Multiple myeloma (MM) is a plasma cell malignancy associated with high levels of monoclonal (M) prot...
Background: Plasmacytoid dendritic cells (pDCs) play prominent roles in mediating innate and adaptiv...